-
1
-
-
36749047453
-
-
Toral-Barza, L.; Zhang, W.-G.; Huang, X.; McDonald, L.; Salaski, E. J.; Barbieri, L. R.; Ding, W.-D.; Krishnamurthy, G.; Hu, Y.; Lucas, J.; Bernan, V. S.; Cai, P.; Levin, J. I.; Mansour, T. S.; Gibbons, J. J.; Abraham, R. T.; Yu, K. Mol. Cancer Ther. 2007, 6, 3028-3038.
-
(2007)
Mol. Cancer Ther
, vol.6
, pp. 3028-3038
-
-
Toral-Barza, L.1
Zhang, W.-G.2
Huang, X.3
McDonald, L.4
Salaski, E.J.5
Barbieri, L.R.6
Ding, W.-D.7
Krishnamurthy, G.8
Hu, Y.9
Lucas, J.10
Bernan, V.S.11
Cai, P.12
Levin, J.I.13
Mansour, T.S.14
Gibbons, J.J.15
Abraham, R.T.16
Yu, K.17
-
2
-
-
58149314643
-
-
Unpublished results
-
Unpublished results.
-
-
-
-
3
-
-
0032943266
-
-
(a) Contant, P.; Haess, M.; Riegl, J; Scalone, M.; Visnick, M. Synthesis 1999, 5, 821-828.
-
(1999)
Synthesis
, vol.5
, pp. 821-828
-
-
Contant, P.1
Haess, M.2
Riegl, J.3
Scalone, M.4
Visnick, M.5
-
4
-
-
0031040493
-
-
(b) Masquelin, T.; Hengartner, U.; Streith, J. Helv. Chem. Acta 1997, 80, 43-58.
-
(1997)
Helv. Chem. Acta
, vol.80
, pp. 43-58
-
-
Masquelin, T.1
Hengartner, U.2
Streith, J.3
-
9
-
-
58149294093
-
-
4 + H, 329.1747; found, 329.1749.
-
4 + H, 329.1747; found, 329.1749.
-
-
-
-
10
-
-
0141712450
-
-
(a) Sharpless, K. B.; Amberg, W.; Bennani, Y. L.; Crispino, G. A.; Hartung, J.; Jeong, K.-S.; Kwong, H.-L.: Morikawa, K.; Wang, D.; Zhang, X.-L. J. Org. Chem. 1992, 57, 2768-2771.
-
(1992)
J. Org. Chem
, vol.57
, pp. 2768-2771
-
-
Sharpless, K.B.1
Amberg, W.2
Bennani, Y.L.3
Crispino, G.A.4
Hartung, J.5
Jeong, K.-S.6
Kwong, H.-L.7
Morikawa, K.8
Wang, D.9
Zhang, X.-L.10
-
11
-
-
0026731391
-
-
(b) Wang, Z.-M.; Zhang, X.-L.; Sharpless, K. B. Tetrahedron Lett. 1992, 33, 6407-6410.
-
(1992)
Tetrahedron Lett
, vol.33
, pp. 6407-6410
-
-
Wang, Z.-M.1
Zhang, X.-L.2
Sharpless, K.B.3
-
12
-
-
58149311564
-
-
Based on the chiral HPLC analysis against the corresponding racemic sample prepared under the same dihydroxylation condition without the chiral auxiliary, the desired enantiomer was formed exclusively
-
Based on the chiral HPLC analysis against the corresponding racemic sample prepared under the same dihydroxylation condition without the chiral auxiliary, the desired enantiomer was formed exclusively.
-
-
-
-
13
-
-
58149303355
-
-
3a (see Supporting Information).
-
3a (see Supporting Information).
-
-
-
-
14
-
-
58149277819
-
-
3 etherate. With all four diastereomers available, chiral HPLC analyses concluded that only the benzylic center was epimerized.
-
3 etherate. With all four diastereomers available, chiral HPLC analyses concluded that only the benzylic center was epimerized.
-
-
-
-
16
-
-
0025950633
-
-
(b) Brimble, M. A.; Ireland, E.; Phythian, S. J. Tetetrahedron Lett. 1991, 32, 6417-6420.
-
(1991)
Tetetrahedron Lett
, vol.32
, pp. 6417-6420
-
-
Brimble, M.A.1
Ireland, E.2
Phythian, S.J.3
-
18
-
-
33748728851
-
-
(b) Giles, G. F. G.; Rickards, R. W.; Senanayake, B. S. J. Chem. Soc., Perkin Trans. 1 1998, 3949-3956.
-
(1998)
J. Chem. Soc., Perkin Trans. 1
, pp. 3949-3956
-
-
Giles, G.F.G.1
Rickards, R.W.2
Senanayake, B.S.3
-
19
-
-
0001109389
-
-
Burgi, H. B.; Dunitz, J. D.; Lehn, J. M.; Wipff, G. Tetrahedron 1974, 30, 1563-1572.
-
(1974)
Tetrahedron
, vol.30
, pp. 1563-1572
-
-
Burgi, H.B.1
Dunitz, J.D.2
Lehn, J.M.3
Wipff, G.4
-
21
-
-
37049091461
-
-
(b) Beckwith, A. L. J.; Easton, C. J.; Serelis, A. K. J. Chem. Soc., Chem. Commun. 1980, 482-483.
-
(1980)
J. Chem. Soc., Chem. Commun
, pp. 482-483
-
-
Beckwith, A.L.J.1
Easton, C.J.2
Serelis, A.K.3
-
22
-
-
58149314641
-
-
A full conformational search was used Macromodel and MMFF94S forcefield, with 5000 steps of PRCG minimization for each conformation (or until completion, if that occurs sooner). There is a slight potential energy advantage to the (11aR,3aR,5R)-3 isomer as compared to the (11aR,3aR,5S)-3 isomer (310 vs 318 kJ/mol, respectively).
-
A full conformational search was used Macromodel and MMFF94S forcefield, with 5000 steps of PRCG minimization for each conformation (or until completion, if that occurs sooner). There is a slight potential energy advantage to the (11aR,3aR,5R)-3 isomer as compared to the (11aR,3aR,5S)-3 isomer (310 vs 318 kJ/mol, respectively).
-
-
-
-
23
-
-
58149303356
-
-
Reviewed in: Larghi, E. L.; Kaufman, T. S. Synthesis 2006, 2, 187-220.
-
Reviewed in: Larghi, E. L.; Kaufman, T. S. Synthesis 2006, 2, 187-220.
-
-
-
-
24
-
-
1842833799
-
-
(a) Micale, N.; Zappala, M.; Grasso, S. Farmaco 2002, 57, 853-859.
-
(2002)
Farmaco
, vol.57
, pp. 853-859
-
-
Micale, N.1
Zappala, M.2
Grasso, S.3
-
25
-
-
0347992920
-
-
(b) Bianchi, D. A.; Cipulli, M. A.; Kaufman, T. S. Eur. J. Org. Chem. 2003, 24, 4731-4736.
-
(2003)
Eur. J. Org. Chem
, vol.24
, pp. 4731-4736
-
-
Bianchi, D.A.1
Cipulli, M.A.2
Kaufman, T.S.3
|